chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Complement factor, Electrocardiogram, Electrocardiogram ambulatory, Erythema, Headache
Clinical narrative: redness; itching below the arm pits; rash; body ache; headache; chills; fever; allergy to vaccine; tachycardia; This spontaneous case was reported by a consumer and describes the occurrence of ALLERGY TO VACCINE (allergy to vaccine), TACHYCARDIA (tachycardia), ERYTHEMA (redness), PRURITUS (itching below the arm pits) and RASH (rash) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Allergy to animal dander (Cat fur allergy). Concomitant products included MULTIVITAMIN FOR WOMEN for an unknown indication.    On 20-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, the patient experienced ALLERGY TO VACCINE (allergy to vaccine). On an unknown date, the patient experienced TACHYCARDIA (tachycardia), ERYTHEMA (redness), PRURITUS (itching below the arm pits), RASH (rash), MYALGIA (body ache), HEADACHE (headache), CHILLS (chills) and PYREXIA (fever). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) (oral) from 23-Apr-2021 to 25-Apr-2021 at an unspecified dose and frequency and CETIRIZINE HYDROCHLORIDE (CETRIZINE) (oral) from 23-Apr-2021 to 25-Apr-2021 at an unspecified dose and frequency. At the time of the report, ALLERGY TO VACCINE (allergy to vaccine), TACHYCARDIA (tachycardia), ERYTHEMA (redness), PRURITUS (itching below the arm pits), RASH (rash), MYALGIA (body ache), HEADACHE (headache), CHILLS (chills) and PYREXIA (fever) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Mar-2021, Heart rate: 115 (High) Above 115 bpm, continued for a month on and off. On 12-Mar-2021, Electrocardiogram: normal (normal) Normal. On 26-Mar-2021, Blood immunoglobulin E: 4.3 (Inconclusive) 4.3 <11.0 ug/L. On 26-Mar-2021, Complement factor: 30.2 (Inconclusive) 30.2 <114 Ku/L. On 26-Mar-2021, Electrocardiogram ambulatory: abnormal (abnormal) Tachycardia. On 20-Apr-2021, Body temperature: 101.4 °F (High) 101.4 F. On 20-Apr-2021, Heart rate: 140 (High) 140 bpm. On 21-Apr-2021, Electrocardiogram: 115 (High) 115 bpm. On 21-Apr-2021, Heart rate: 135 (High) 135 bpm. On 23-Apr-2021, Blood pressure measurement: 116/76 (Low) 116/76 mmhg.         This case was linked to MOD-2021-044263 (Patient Link).
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate, Myalgia, Pruritus, Pyrexia, Rash
Clinical narrative: redness; itching below the arm pits; rash; body ache; headache; chills; fever; allergy to vaccine; tachycardia; This spontaneous case was reported by a consumer and describes the occurrence of ALLERGY TO VACCINE (allergy to vaccine), TACHYCARDIA (tachycardia), ERYTHEMA (redness), PRURITUS (itching below the arm pits) and RASH (rash) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Allergy to animal dander (Cat fur allergy). Concomitant products included MULTIVITAMIN FOR WOMEN for an unknown indication.    On 20-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, the patient experienced ALLERGY TO VACCINE (allergy to vaccine). On an unknown date, the patient experienced TACHYCARDIA (tachycardia), ERYTHEMA (redness), PRURITUS (itching below the arm pits), RASH (rash), MYALGIA (body ache), HEADACHE (headache), CHILLS (chills) and PYREXIA (fever). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) (oral) from 23-Apr-2021 to 25-Apr-2021 at an unspecified dose and frequency and CETIRIZINE HYDROCHLORIDE (CETRIZINE) (oral) from 23-Apr-2021 to 25-Apr-2021 at an unspecified dose and frequency. At the time of the report, ALLERGY TO VACCINE (allergy to vaccine), TACHYCARDIA (tachycardia), ERYTHEMA (redness), PRURITUS (itching below the arm pits), RASH (rash), MYALGIA (body ache), HEADACHE (headache), CHILLS (chills) and PYREXIA (fever) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Mar-2021, Heart rate: 115 (High) Above 115 bpm, continued for a month on and off. On 12-Mar-2021, Electrocardiogram: normal (normal) Normal. On 26-Mar-2021, Blood immunoglobulin E: 4.3 (Inconclusive) 4.3 <11.0 ug/L. On 26-Mar-2021, Complement factor: 30.2 (Inconclusive) 30.2 <114 Ku/L. On 26-Mar-2021, Electrocardiogram ambulatory: abnormal (abnormal) Tachycardia. On 20-Apr-2021, Body temperature: 101.4 °F (High) 101.4 F. On 20-Apr-2021, Heart rate: 140 (High) 140 bpm. On 21-Apr-2021, Electrocardiogram: 115 (High) 115 bpm. On 21-Apr-2021, Heart rate: 135 (High) 135 bpm. On 23-Apr-2021, Blood pressure measurement: 116/76 (Low) 116/76 mmhg.         This case was linked to MOD-2021-044263 (Patient Link).
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Tachycardia
Clinical narrative: redness; itching below the arm pits; rash; body ache; headache; chills; fever; allergy to vaccine; tachycardia; This spontaneous case was reported by a consumer and describes the occurrence of ALLERGY TO VACCINE (allergy to vaccine), TACHYCARDIA (tachycardia), ERYTHEMA (redness), PRURITUS (itching below the arm pits) and RASH (rash) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Allergy to animal dander (Cat fur allergy). Concomitant products included MULTIVITAMIN FOR WOMEN for an unknown indication.    On 20-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, the patient experienced ALLERGY TO VACCINE (allergy to vaccine). On an unknown date, the patient experienced TACHYCARDIA (tachycardia), ERYTHEMA (redness), PRURITUS (itching below the arm pits), RASH (rash), MYALGIA (body ache), HEADACHE (headache), CHILLS (chills) and PYREXIA (fever). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) (oral) from 23-Apr-2021 to 25-Apr-2021 at an unspecified dose and frequency and CETIRIZINE HYDROCHLORIDE (CETRIZINE) (oral) from 23-Apr-2021 to 25-Apr-2021 at an unspecified dose and frequency. At the time of the report, ALLERGY TO VACCINE (allergy to vaccine), TACHYCARDIA (tachycardia), ERYTHEMA (redness), PRURITUS (itching below the arm pits), RASH (rash), MYALGIA (body ache), HEADACHE (headache), CHILLS (chills) and PYREXIA (fever) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Mar-2021, Heart rate: 115 (High) Above 115 bpm, continued for a month on and off. On 12-Mar-2021, Electrocardiogram: normal (normal) Normal. On 26-Mar-2021, Blood immunoglobulin E: 4.3 (Inconclusive) 4.3 <11.0 ug/L. On 26-Mar-2021, Complement factor: 30.2 (Inconclusive) 30.2 <114 Ku/L. On 26-Mar-2021, Electrocardiogram ambulatory: abnormal (abnormal) Tachycardia. On 20-Apr-2021, Body temperature: 101.4 °F (High) 101.4 F. On 20-Apr-2021, Heart rate: 140 (High) 140 bpm. On 21-Apr-2021, Electrocardiogram: 115 (High) 115 bpm. On 21-Apr-2021, Heart rate: 135 (High) 135 bpm. On 23-Apr-2021, Blood pressure measurement: 116/76 (Low) 116/76 mmhg.         This case was linked to MOD-2021-044263 (Patient Link).
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema multiforme, Fatigue, Headache, Pain, Product dose omission issue
Clinical narrative: developed a rash; Headache; Fatigue; Little bit of a fever; I did not receive the second dose; I got home and my ears were red, neck was red/Next morning entire trunk was red, skin right red; I had an allergic reaction an hour after the shot, no anaphylaxis or difficulty breathing only a skin reaction; From ears to trunk it looked like a second degree sun burn; Body ache; This spontaneous case was reported by a nurse and describes the occurrence of ERYTHEMA MULTIFORME (I got home and my ears were red, neck was red/Next morning entire trunk was red, skin right red) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in December 2020. Concomitant products included LOSARTAN, ROSUVASTATIN and LEVOCETIRIZINE for an unknown indication.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced ERYTHEMA MULTIFORME (I got home and my ears were red, neck was red/Next morning entire trunk was red, skin right red) (seriousness criterion medically significant), SKIN REACTION (I had an allergic reaction an hour after the shot, no anaphylaxis or difficulty breathing only a skin reaction), SUNBURN (From ears to trunk it looked like a second degree sun burn), PAIN (Body ache), HEADACHE (Headache), FATIGUE (Fatigue), PYREXIA (Little bit of a fever) and PRODUCT DOSE OMISSION ISSUE (I did not receive the second dose). On 25-Feb-2021, the patient experienced RASH (developed a rash). On 24-Feb-2021, PRODUCT DOSE OMISSION ISSUE (I did not receive the second dose) had resolved. On 01-Mar-2021, ERYTHEMA MULTIFORME (I got home and my ears were red, neck was red/Next morning entire trunk was red, skin right red), SKIN REACTION (I had an allergic reaction an hour after the shot, no anaphylaxis or difficulty breathing only a skin reaction), SUNBURN (From ears to trunk it looked like a second degree sun burn), PAIN (Body ache), RASH (developed a rash), HEADACHE (Headache), FATIGUE (Fatigue) and PYREXIA (Little bit of a fever) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided by reporter.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Rash, Skin reaction, Sunburn
Clinical narrative: developed a rash; Headache; Fatigue; Little bit of a fever; I did not receive the second dose; I got home and my ears were red, neck was red/Next morning entire trunk was red, skin right red; I had an allergic reaction an hour after the shot, no anaphylaxis or difficulty breathing only a skin reaction; From ears to trunk it looked like a second degree sun burn; Body ache; This spontaneous case was reported by a nurse and describes the occurrence of ERYTHEMA MULTIFORME (I got home and my ears were red, neck was red/Next morning entire trunk was red, skin right red) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in December 2020. Concomitant products included LOSARTAN, ROSUVASTATIN and LEVOCETIRIZINE for an unknown indication.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced ERYTHEMA MULTIFORME (I got home and my ears were red, neck was red/Next morning entire trunk was red, skin right red) (seriousness criterion medically significant), SKIN REACTION (I had an allergic reaction an hour after the shot, no anaphylaxis or difficulty breathing only a skin reaction), SUNBURN (From ears to trunk it looked like a second degree sun burn), PAIN (Body ache), HEADACHE (Headache), FATIGUE (Fatigue), PYREXIA (Little bit of a fever) and PRODUCT DOSE OMISSION ISSUE (I did not receive the second dose). On 25-Feb-2021, the patient experienced RASH (developed a rash). On 24-Feb-2021, PRODUCT DOSE OMISSION ISSUE (I did not receive the second dose) had resolved. On 01-Mar-2021, ERYTHEMA MULTIFORME (I got home and my ears were red, neck was red/Next morning entire trunk was red, skin right red), SKIN REACTION (I had an allergic reaction an hour after the shot, no anaphylaxis or difficulty breathing only a skin reaction), SUNBURN (From ears to trunk it looked like a second degree sun burn), PAIN (Body ache), RASH (developed a rash), HEADACHE (Headache), FATIGUE (Fatigue) and PYREXIA (Little bit of a fever) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided by reporter.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Mild pain on left leg; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Mild pain on left leg) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013M20A and 001A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Feb-2021, the patient experienced PAIN IN EXTREMITY (Mild pain on left leg) (seriousness criterion medically significant). At the time of the report, PAIN IN EXTREMITY (Mild pain on left leg) had resolved.            It is stated that patient was taking regular prescribed medications. Treatment information was not provided.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable.  Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.   This case was linked to MOD-2021-280250 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Deep vein thrombosis, Pain in extremity, Peripheral swelling, Ultrasound Doppler
Clinical narrative: blood clot in the left leg; severe left leg pain; mild swelling of left leg; This spontaneous case was reported by a consumer and describes the occurrence of DEEP VEIN THROMBOSIS (blood clot in the left leg) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In May 2021, the patient experienced DEEP VEIN THROMBOSIS (blood clot in the left leg) (seriousness criterion medically significant), PAIN IN EXTREMITY (severe left leg pain) and PERIPHERAL SWELLING (mild swelling of left leg). The patient was treated with MENTHOL, METHYL SALICYLATE (BENGAY [MENTHOL;METHYL SALICYLATE]) for Leg pain, at an unspecified dose and frequency and APIXABAN (ELIQUIS) ongoing since an unknown date for Clot blood, at an unspecified dose and frequency. At the time of the report, DEEP VEIN THROMBOSIS (blood clot in the left leg), PAIN IN EXTREMITY (severe left leg pain) and PERIPHERAL SWELLING (mild swelling of left leg) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In May 2021, Ultrasound Doppler: clot in leg (abnormal) clot in leg.         Patient confirmed taking regular prescribed medications but refused to give information about their names. The patient was prescribed to take a blood thinner medication and that she will be taking it for a long time.  Company comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   This case was linked to MOD-2021-280246 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Thrombosis
Clinical narrative: blood clot in her left leg; This spontaneous case was reported by a consumer and describes the occurrence of THROMBOSIS (blood clot in her left leg) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced THROMBOSIS (blood clot in her left leg) (seriousness criterion medically significant). At the time of the report, THROMBOSIS (blood clot in her left leg) outcome was unknown.            No concomitant medications were reported. No treatment information was provided. Company comment: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Sex: U
Vaccine: COVID19
Symptoms: Muscle twitching
Clinical narrative: Right arm twitching; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 09-Aug-2021 and was forwarded to Moderna on 09-Aug-2021.    This spontaneous case was reported by a patient and describes the occurrence of MUSCLE TWITCHING (Right arm twitching) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MUSCLE TWITCHING (Right arm twitching). At the time of the report, MUSCLE TWITCHING (Right arm twitching) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No information on concomitant medications were reported. No information on treatment medication was reported.   Reporter did not allow further contact
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Chest pain, Decreased appetite, Diaphragmalgia, Diarrhoea
Clinical narrative: she has had spasms in her left leg and in her arms; Headache; Nausea; Diarrhea; Upset stomach; Numbness on finger tips; lack of appetite/complete loss of appetite; Chest Pain; Diaphragmatic pain; Dizziness; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), ABDOMINAL DISCOMFORT (Upset stomach), HYPOAESTHESIA (Numbness on finger tips), DECREASED APPETITE (lack of appetite/complete loss of appetite) and CHEST PAIN (Chest Pain) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. FA7485) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 06-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Aug-2021, the patient experienced DIARRHOEA (Diarrhea), ABDOMINAL DISCOMFORT (Upset stomach), HYPOAESTHESIA (Numbness on finger tips), DECREASED APPETITE (lack of appetite/complete loss of appetite), CHEST PAIN (Chest Pain), DIAPHRAGMALGIA (Diaphragmatic pain), DIZZINESS (Dizziness), HEADACHE (Headache) and NAUSEA (Nausea). On an unknown date, the patient experienced MUSCLE SPASMS (she has had spasms in her left leg and in her arms). The patient was treated with PARACETAMOL (TYLENOL) for Headache, at a dose of 1 dosage form. On 07-Aug-2021, HEADACHE (Headache) had resolved. At the time of the report, DIARRHOEA (Diarrhea), ABDOMINAL DISCOMFORT (Upset stomach), HYPOAESTHESIA (Numbness on finger tips), DECREASED APPETITE (lack of appetite/complete loss of appetite), CHEST PAIN (Chest Pain), DIAPHRAGMALGIA (Diaphragmatic pain), DIZZINESS (Dizziness), MUSCLE SPASMS (she has had spasms in her left leg and in her arms) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were reported.  She has tried to find the Lot number on the Moderna website and cannot find the lot number on the Moderna website.  She states the number written on her card is FA7485.  The lot number written on her boyfriend's card which she was able to find on the Moderna website was 939902. When she called the pharmacy they stated they may have just written the number down wrong on her card since she and her boyfriend received them together.   This case was linked to MODERNATX, INC.-MOD-2021-127695 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 09-Aug-2021: Event (Muscle spasms) added. On 09-Aug-2021: Follow up contains Non-Significant Information; Sender's Comments:  MODERNATX, INC.-MOD-2021-127695:(crosslink case)
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Hypoaesthesia, Muscle spasms, Nausea
Clinical narrative: she has had spasms in her left leg and in her arms; Headache; Nausea; Diarrhea; Upset stomach; Numbness on finger tips; lack of appetite/complete loss of appetite; Chest Pain; Diaphragmatic pain; Dizziness; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), ABDOMINAL DISCOMFORT (Upset stomach), HYPOAESTHESIA (Numbness on finger tips), DECREASED APPETITE (lack of appetite/complete loss of appetite) and CHEST PAIN (Chest Pain) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. FA7485) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 06-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Aug-2021, the patient experienced DIARRHOEA (Diarrhea), ABDOMINAL DISCOMFORT (Upset stomach), HYPOAESTHESIA (Numbness on finger tips), DECREASED APPETITE (lack of appetite/complete loss of appetite), CHEST PAIN (Chest Pain), DIAPHRAGMALGIA (Diaphragmatic pain), DIZZINESS (Dizziness), HEADACHE (Headache) and NAUSEA (Nausea). On an unknown date, the patient experienced MUSCLE SPASMS (she has had spasms in her left leg and in her arms). The patient was treated with PARACETAMOL (TYLENOL) for Headache, at a dose of 1 dosage form. On 07-Aug-2021, HEADACHE (Headache) had resolved. At the time of the report, DIARRHOEA (Diarrhea), ABDOMINAL DISCOMFORT (Upset stomach), HYPOAESTHESIA (Numbness on finger tips), DECREASED APPETITE (lack of appetite/complete loss of appetite), CHEST PAIN (Chest Pain), DIAPHRAGMALGIA (Diaphragmatic pain), DIZZINESS (Dizziness), MUSCLE SPASMS (she has had spasms in her left leg and in her arms) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were reported.  She has tried to find the Lot number on the Moderna website and cannot find the lot number on the Moderna website.  She states the number written on her card is FA7485.  The lot number written on her boyfriend's card which she was able to find on the Moderna website was 939902. When she called the pharmacy they stated they may have just written the number down wrong on her card since she and her boyfriend received them together.   This case was linked to MODERNATX, INC.-MOD-2021-127695 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 09-Aug-2021: Event (Muscle spasms) added. On 09-Aug-2021: Follow up contains Non-Significant Information; Sender's Comments:  MODERNATX, INC.-MOD-2021-127695:(crosslink case)
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Cardiac flutter, Chest discomfort, Chest pain, Dyspnoea, Electrocardiogram
Clinical narrative: more than 42 days have passed for second dose; fluttering heart; chest pain; heart palpitations; shortness of breath; feeling of tightness in the chest; doctor said that could be inflammation of some kind; This spontaneous case was reported by a consumer and describes the occurrence of CARDIAC FLUTTER (fluttering heart) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 03-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced CARDIAC FLUTTER (fluttering heart) (seriousness criterion medically significant), CHEST PAIN (chest pain), PALPITATIONS (heart palpitations), DYSPNOEA (shortness of breath), CHEST DISCOMFORT (feeling of tightness in the chest) and INFLAMMATION (doctor said that could be inflammation of some kind). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (more than 42 days have passed for second dose). At the time of the report, CARDIAC FLUTTER (fluttering heart), CHEST PAIN (chest pain), PALPITATIONS (heart palpitations), DYSPNOEA (shortness of breath), CHEST DISCOMFORT (feeling of tightness in the chest), INFLAMMATION (doctor said that could be inflammation of some kind) and PRODUCT DOSE OMISSION ISSUE (more than 42 days have passed for second dose) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Electrocardiogram: low qrs (abnormal) EKG said Low QRS.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment drug information provided.  No concomitant drug information provided.  Within 30 minutes of vaccination patient had chest pain, heart palpitations/fluttering heart, shortness of breath and a feeling of tightness in the chest. Patients vitals were Ok The symptoms went on for 2 weeks but subsided little by little. Patient was scared to get a 2nd shot.  Company Comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   Most recent FOLLOW-UP information incorporated above includes: On 09-Aug-2021: Follow up document received has AE contact information updated.; Sender's Comments: .Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Inflammation, Palpitations, Product dose omission issue
Clinical narrative: more than 42 days have passed for second dose; fluttering heart; chest pain; heart palpitations; shortness of breath; feeling of tightness in the chest; doctor said that could be inflammation of some kind; This spontaneous case was reported by a consumer and describes the occurrence of CARDIAC FLUTTER (fluttering heart) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 03-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced CARDIAC FLUTTER (fluttering heart) (seriousness criterion medically significant), CHEST PAIN (chest pain), PALPITATIONS (heart palpitations), DYSPNOEA (shortness of breath), CHEST DISCOMFORT (feeling of tightness in the chest) and INFLAMMATION (doctor said that could be inflammation of some kind). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (more than 42 days have passed for second dose). At the time of the report, CARDIAC FLUTTER (fluttering heart), CHEST PAIN (chest pain), PALPITATIONS (heart palpitations), DYSPNOEA (shortness of breath), CHEST DISCOMFORT (feeling of tightness in the chest), INFLAMMATION (doctor said that could be inflammation of some kind) and PRODUCT DOSE OMISSION ISSUE (more than 42 days have passed for second dose) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Electrocardiogram: low qrs (abnormal) EKG said Low QRS.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment drug information provided.  No concomitant drug information provided.  Within 30 minutes of vaccination patient had chest pain, heart palpitations/fluttering heart, shortness of breath and a feeling of tightness in the chest. Patients vitals were Ok The symptoms went on for 2 weeks but subsided little by little. Patient was scared to get a 2nd shot.  Company Comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   Most recent FOLLOW-UP information incorporated above includes: On 09-Aug-2021: Follow up document received has AE contact information updated.; Sender's Comments: .Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Mistakenly injected to 15 yr old; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Mistakenly injected to 15 yr old) in a 15-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 009D21A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Aug-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Mistakenly injected to 15 yr old). On 07-Aug-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Mistakenly injected to 15 yr old) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.   No treatment information was provided.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Vaccination site pain
Clinical narrative: Three bruises on her stomach/3 bruises on my stomach/bruise; Sore arm (injection site); This spontaneous case was reported by a consumer and describes the occurrence of CONTUSION (Three bruises on her stomach/3 bruises on my stomach/bruise) and VACCINATION SITE PAIN (Sore arm (injection site)) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 088D21A) for COVID-19 vaccination.     Concurrent medical conditions included Gluten sensitivity, Food allergy (tomato based food allergy), Food allergy (beets allergy), Drug allergy (NSAIDS Allergy), Drug allergy (doxycycline allergy), Drug allergy (Percocet allergy) and Hypersensitivity (outdoor smell allergy).    On 06-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Aug-2021, the patient experienced VACCINATION SITE PAIN (Sore arm (injection site)). On 07-Aug-2021, the patient experienced CONTUSION (Three bruises on her stomach/3 bruises on my stomach/bruise). On 06-Aug-2021, VACCINATION SITE PAIN (Sore arm (injection site)) had resolved. At the time of the report, CONTUSION (Three bruises on her stomach/3 bruises on my stomach/bruise) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications or treatment details were reported.   Most recent FOLLOW-UP information incorporated above includes: On 09-Aug-2021: No new information was updated.
Sex: U
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Lightheadedness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Lightheadedness) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Lightheadedness). At the time of the report, DIZZINESS (Lightheadedness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported.  Treatment information not reported.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Bedridden, Illness, Intentional dose omission, Malaise, Migraine
Clinical narrative: first dose had me on deaths bed; could not move for 2-3 weeks/could not move the arm without sharp pain going down the whole body; arm hurt for 2 weeks/I could not move my arm; had severe migraines for 2-3 weeks; Adverse reactions to the vaccine; reaction made very sick/ Iwas very sick; had a sinus infection; slept all day everyday; not feeling well; could not get out of bed; refused the second dose; This spontaneous case was reported by a consumer and describes the occurrence of NEAR DEATH EXPERIENCE (first dose had me on deaths bed) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NEAR DEATH EXPERIENCE (first dose had me on deaths bed) (seriousness criterion medically significant), VACCINATION COMPLICATION (Adverse reactions to the vaccine), ILLNESS (reaction made very sick/ Iwas very sick), MOBILITY DECREASED (could not move for 2-3 weeks/could not move the arm without sharp pain going down the whole body), SINUSITIS (had a sinus infection), PAIN IN EXTREMITY (arm hurt for 2 weeks/I could not move my arm), MIGRAINE (had severe migraines for 2-3 weeks), SOMNOLENCE (slept all day everyday), MALAISE (not feeling well), BEDRIDDEN (could not get out of bed) and INTENTIONAL DOSE OMISSION (refused the second dose). At the time of the report, NEAR DEATH EXPERIENCE (first dose had me on deaths bed), VACCINATION COMPLICATION (Adverse reactions to the vaccine), ILLNESS (reaction made very sick/ Iwas very sick), MOBILITY DECREASED (could not move for 2-3 weeks/could not move the arm without sharp pain going down the whole body), SINUSITIS (had a sinus infection), PAIN IN EXTREMITY (arm hurt for 2 weeks/I could not move my arm), MIGRAINE (had severe migraines for 2-3 weeks), SOMNOLENCE (slept all day everyday), MALAISE (not feeling well), BEDRIDDEN (could not get out of bed) and INTENTIONAL DOSE OMISSION (refused the second dose) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was withdrawn on an unknown date.       No relevant concomitant medication information provided.  No relevant treatment medication information provided.  Patient had refused for second dose as first dose had him on deaths bed.  Company comment: Very limited information regarding these events has been provided at this time. Further information has been requested.; Sender's Comments: Very limited information regarding these events has been provided at this time. Further information has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Mobility decreased, Near death experience, Pain in extremity, Sinusitis, Somnolence
Clinical narrative: first dose had me on deaths bed; could not move for 2-3 weeks/could not move the arm without sharp pain going down the whole body; arm hurt for 2 weeks/I could not move my arm; had severe migraines for 2-3 weeks; Adverse reactions to the vaccine; reaction made very sick/ Iwas very sick; had a sinus infection; slept all day everyday; not feeling well; could not get out of bed; refused the second dose; This spontaneous case was reported by a consumer and describes the occurrence of NEAR DEATH EXPERIENCE (first dose had me on deaths bed) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NEAR DEATH EXPERIENCE (first dose had me on deaths bed) (seriousness criterion medically significant), VACCINATION COMPLICATION (Adverse reactions to the vaccine), ILLNESS (reaction made very sick/ Iwas very sick), MOBILITY DECREASED (could not move for 2-3 weeks/could not move the arm without sharp pain going down the whole body), SINUSITIS (had a sinus infection), PAIN IN EXTREMITY (arm hurt for 2 weeks/I could not move my arm), MIGRAINE (had severe migraines for 2-3 weeks), SOMNOLENCE (slept all day everyday), MALAISE (not feeling well), BEDRIDDEN (could not get out of bed) and INTENTIONAL DOSE OMISSION (refused the second dose). At the time of the report, NEAR DEATH EXPERIENCE (first dose had me on deaths bed), VACCINATION COMPLICATION (Adverse reactions to the vaccine), ILLNESS (reaction made very sick/ Iwas very sick), MOBILITY DECREASED (could not move for 2-3 weeks/could not move the arm without sharp pain going down the whole body), SINUSITIS (had a sinus infection), PAIN IN EXTREMITY (arm hurt for 2 weeks/I could not move my arm), MIGRAINE (had severe migraines for 2-3 weeks), SOMNOLENCE (slept all day everyday), MALAISE (not feeling well), BEDRIDDEN (could not get out of bed) and INTENTIONAL DOSE OMISSION (refused the second dose) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was withdrawn on an unknown date.       No relevant concomitant medication information provided.  No relevant treatment medication information provided.  Patient had refused for second dose as first dose had him on deaths bed.  Company comment: Very limited information regarding these events has been provided at this time. Further information has been requested.; Sender's Comments: Very limited information regarding these events has been provided at this time. Further information has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: first dose had me on deaths bed; could not move for 2-3 weeks/could not move the arm without sharp pain going down the whole body; arm hurt for 2 weeks/I could not move my arm; had severe migraines for 2-3 weeks; Adverse reactions to the vaccine; reaction made very sick/ Iwas very sick; had a sinus infection; slept all day everyday; not feeling well; could not get out of bed; refused the second dose; This spontaneous case was reported by a consumer and describes the occurrence of NEAR DEATH EXPERIENCE (first dose had me on deaths bed) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NEAR DEATH EXPERIENCE (first dose had me on deaths bed) (seriousness criterion medically significant), VACCINATION COMPLICATION (Adverse reactions to the vaccine), ILLNESS (reaction made very sick/ Iwas very sick), MOBILITY DECREASED (could not move for 2-3 weeks/could not move the arm without sharp pain going down the whole body), SINUSITIS (had a sinus infection), PAIN IN EXTREMITY (arm hurt for 2 weeks/I could not move my arm), MIGRAINE (had severe migraines for 2-3 weeks), SOMNOLENCE (slept all day everyday), MALAISE (not feeling well), BEDRIDDEN (could not get out of bed) and INTENTIONAL DOSE OMISSION (refused the second dose). At the time of the report, NEAR DEATH EXPERIENCE (first dose had me on deaths bed), VACCINATION COMPLICATION (Adverse reactions to the vaccine), ILLNESS (reaction made very sick/ Iwas very sick), MOBILITY DECREASED (could not move for 2-3 weeks/could not move the arm without sharp pain going down the whole body), SINUSITIS (had a sinus infection), PAIN IN EXTREMITY (arm hurt for 2 weeks/I could not move my arm), MIGRAINE (had severe migraines for 2-3 weeks), SOMNOLENCE (slept all day everyday), MALAISE (not feeling well), BEDRIDDEN (could not get out of bed) and INTENTIONAL DOSE OMISSION (refused the second dose) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was withdrawn on an unknown date.       No relevant concomitant medication information provided.  No relevant treatment medication information provided.  Patient had refused for second dose as first dose had him on deaths bed.  Company comment: Very limited information regarding these events has been provided at this time. Further information has been requested.; Sender's Comments: Very limited information regarding these events has been provided at this time. Further information has been requested.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Decreased appetite, Fatigue, Feeding disorder
Clinical narrative: unable to eat; feels very weak/ weak; lack of appetite; Tired; This spontaneous case was reported by a nurse and describes the occurrence of FEEDING DISORDER (unable to eat), ASTHENIA (feels very weak/ weak), DECREASED APPETITE (lack of appetite) and FATIGUE (Tired) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 041L20A and 025L20A) for COVID-19 vaccination.     The patient's past medical history included Cancer (Cancer survivor) and Back surgery. Concomitant products included GABAPENTINE, RETINOL (VITAMINE A) and ASCORBIC ACID (VITAMINE C) for an unknown indication.   On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FEEDING DISORDER (unable to eat), ASTHENIA (feels very weak/ weak), DECREASED APPETITE (lack of appetite) and FATIGUE (Tired). At the time of the report, FEEDING DISORDER (unable to eat), DECREASED APPETITE (lack of appetite) and FATIGUE (Tired) outcome was unknown and ASTHENIA (feels very weak/ weak) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient states that there was no reaction to the 1st dose, only with the 2nd dose.  No Treatment information was reported.   Most recent FOLLOW-UP information incorporated above includes: On 09-Aug-2021: Additional information received captured patient demographics, product details, concomitant medications, events and outcome.
Age: 15.0
Sex: U
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Administration of the vaccine to a 15 years old patient; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Administration of the vaccine to a 15 years old patient) in a 15-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.   No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Administration of the vaccine to a 15 years old patient). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Administration of the vaccine to a 15 years old patient) had resolved.          No Concomitant medications were reported. No Treatment information was reported.; Sender's Comments: This report refers to a case of product administration to a patient of an inappropriate age (15 year-old) for mRNA-1273, lot # unknown, with no associated AEs. Patient will continue to be contacted for further monitoring of AEs.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Myalgia, Swelling face, Vaccination site pain
Clinical narrative: Body aches; face was swollen after receiving the second dose; did feel pain in  the injection site the day of the administration of the vaccine/pain in the arm; Chills; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING FACE (face was swollen after receiving the second dose), VACCINATION SITE PAIN (did feel pain in  the injection site the day of the administration of the vaccine/pain in the arm), MYALGIA (Body aches) and CHILLS (Chills) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032b21a) for COVID-19 vaccination.     Concurrent medical conditions included Anxiety. Concomitant products included ESCITALOPRAM for Anxiety.    On 19-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Apr-2021, the patient experienced VACCINATION SITE PAIN (did feel pain in  the injection site the day of the administration of the vaccine/pain in the arm) and CHILLS (Chills). On 14-Jul-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced SWELLING FACE (face was swollen after receiving the second dose). On an unknown date, the patient experienced MYALGIA (Body aches). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) on 20-Apr-2021 for Myalgia, at an unspecified dose and frequency. At the time of the report, SWELLING FACE (face was swollen after receiving the second dose) had not resolved and VACCINATION SITE PAIN (did feel pain in  the injection site the day of the administration of the vaccine/pain in the arm), MYALGIA (Body aches) and CHILLS (Chills) outcome was unknown.            Most recent FOLLOW-UP information incorporated above includes: On 14-Aug-2021: Follow-up information received contains  - Events added  are pain in arm, chills and patient DOB corrected.
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (fever). At the time of the report, PYREXIA (fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment medications were reported.